How Amgen Lost the PCSK9 Patent War

The Cowboy of Generic Drugs

The Day Novartis Chose Discovery

The Hollow Men of Hims

Against "Against Life Extension"

Mr. Secretary, Reclassify the Statin

China's leap in pharma: slow and fast trends behind its rise